Inari Medical, Inc. (NARI) stock declined over -0.10%, trading at $79.42 on NASDAQ, down from the previous close of $79.50. The stock opened at $79.53, fluctuating between $79.42 and $79.66 in the recent session.
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Employees | 1300 |
Beta | 0.96 |
Sales or Revenue | $493.63M |
5Y Sales Change% | 56.237% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
Inari Medical, Inc. (NASDAQ: NARI) stock price is $79.42 in the last trading session. During the trading session, NARI stock reached the peak price of $79.66 while $79.42 was the lowest point it dropped to. The percentage change in NARI stock occurred in the recent session was -0.1% while the dollar amount for the price change in NARI stock was -$0.08.
The NASDAQ listed NARI is part of Medical - Devices industry that operates in the broader Healthcare sector. Inari Medical, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Mitchell C. Hill
Chief Financial Officer
Ms. Dena Truelove
Vice President of HR
Mr. Eric Khairy
Senior Vice President of Marketing
Dr. Thomas M. Tu M.D.
Chief Medical Officer
Ms. Janet Byk
Vice President of Fin. & Accounting
Mr. Paul A. Koehn
Senior Vice President of Operations
Mr. Andrew J. Hykes
Chief Executive Officer, Pres & Director
Mr. William H. Hoffman
Chief Executive Officer, Pres & Director
Ms. Angela Ahmad
Gen. Counsel & Sec.
Mr. John R. Borrell
Senior Vice President of Sales
Mr. Brian Strauss
Senior Vice President of Engineering
Ms. Tara Dunn
Senior Vice President of Clinical Affairs & Market Devel.
NARI's closing price is 116.23% higher than its 52-week low of $36.73 where as its distance from 52-week high of $79.69 is -0.34%.
Number of NARI employees currently stands at 1,300.
Official Website of NARI is: https://www.inarimedical.com
NARI could be contacted at phone 877 923 4747 and can also be accessed through its website. NARI operates from 6001 Oak Canyon, Irvine, CA 92618, United States.
NARI stock volume for the day was 2.32M shares. The average number of NARI shares traded daily for last 3 months was 2.19M.
The market value of NARI currently stands at $4.65B with its latest stock price at $79.42 and 58.56M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com